Latest News Archive
Please select Category, Year, and then Month to display items
18 August 2021
|
Story Division of Student Affairs
![]()
The SRC Elections for the elective portfolios will be held from 12 to 15 October 2021 for the Bloemfontein, Qwaqwa and South Campuses.
Following the official announcement of the election schedule on 16 August 2021, the processes below are to unfold:
a. Candidate nominations for CSRC elective portfolios will open on 23 August, until 10 September 2021;
b. Ex-officio portfolio elections will take place on 11 October 2021;
c. Manifesto launches will take place via webinars from 15 September to 11 October 2021;
d. Declaration of final election results will be on 18 October 2021.
KDBS Consulting (Pty) Ltd has been appointed as the independent Chief Elections Administrator that is to oversee and manage the 2021 online SRC elections.
A website will be launched to provide updated information regarding all processes that are to unfold. A detailed schedule will also be made available via the official elections website that will be hosted by the service provider.
For any queries related to the elections, communication is to be sent via email to the Chief Election Administrator at
ufssrcelections@kdbs.co.za Communication to the election helpdesk may also be sent via direct call or on WhatsApp at
+27 0 61 452 4499.
Election specific notifications will be communicated via email and SMS.
Official elections will take place from 12-15 October 2021.
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004